Healthcare provider profile · identity verified

Gerri Lynn Steele, D.O.

Internal Medicine · CARLISLE, PA · NPI 1023288305

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	591	183
Lisinopril	Lisinopril	430	127
Levothyroxine Sodium	Levothyroxine Sodium	366	100
Amlodipine Besylate	Amlodipine Besylate	293	90
Omeprazole	Omeprazole	261	85
Metoprolol Succinate	Metoprolol Succinate	242	72
Losartan Potassium	Losartan Potassium	238	72
Gabapentin	Gabapentin	221	72
Metformin Hcl	Metformin Hcl	202	56
Simvastatin	Simvastatin	179	51
Pantoprazole Sodium	Pantoprazole Sodium	162	58
Furosemide	Furosemide	149	44
Hydrochlorothiazide	Hydrochlorothiazide	140	46
Glipizide	Glipizide	136	39
Eliquis	Apixaban	134	33
Citalopram Hbr	Citalopram Hydrobromide	123	34
Alendronate Sodium	Alendronate Sodium	121	38
Rosuvastatin Calcium	Rosuvastatin Calcium	119	39
Sertraline Hcl	Sertraline Hcl	119	34
Famotidine	Famotidine	113	40
Bupropion Xl	Bupropion Hcl	102	26
Jardiance	Empagliflozin	95	19
Albuterol Sulfate Hfa	Albuterol Sulfate	92	34
Buspirone Hcl	Buspirone Hcl	87	28
Pravastatin Sodium	Pravastatin Sodium	83	26
Trazodone Hcl	Trazodone Hcl	82	33
Clopidogrel	Clopidogrel Bisulfate	81	26
Metoprolol Tartrate	Metoprolol Tartrate	77	25
Prednisone	Prednisone	76	73
Clonidine Hcl	Clonidine Hcl	75	22
Tamsulosin Hcl	Tamsulosin Hcl	75	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	37
Carvedilol	Carvedilol	70	23
Duloxetine Hcl	Duloxetine Hcl	66	22
Fluticasone Propionate	Fluticasone Propionate	66	35
Allopurinol	Allopurinol	63	20
Ezetimibe	Ezetimibe	61	20
Ozempic	Semaglutide	61	14
Potassium Chloride	Potassium Chloride	61	26
Breo Ellipta	Fluticasone/Vilanterol	60	13
Meloxicam	Meloxicam	60	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	18
Montelukast Sodium	Montelukast Sodium	58	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	suppressed
Lorazepam	Lorazepam	55	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	16
Tramadol Hcl	Tramadol Hcl	53	15
Warfarin Sodium	Warfarin Sodium	46	12
Azithromycin	Azithromycin	45	45
Escitalopram Oxalate	Escitalopram Oxalate	44	16
Chlorthalidone	Chlorthalidone	43	15
Januvia	Sitagliptin Phosphate	42	suppressed
Atenolol	Atenolol	40	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	14
Fenofibrate	Fenofibrate Nanocrystallized	37	12
Hydralazine Hcl	Hydralazine Hcl	36	13
Spironolactone	Spironolactone	35	11
Amitriptyline Hcl	Amitriptyline Hcl	34	12
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Metformin Hcl Er	Metformin Hcl	33	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	32	27
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Valsartan	Valsartan	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	12
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Nystatin	Nystatin	29	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	23
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	12
Glipizide Er	Glipizide	24	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	14
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Amoxicillin	Amoxicillin	23	14
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Repaglinide	Repaglinide	21	11
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	16
Fenofibrate	Fenofibrate	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Celecoxib	Celecoxib	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Megestrol Acetate	Megestrol Acetate	15	suppressed
Nitroglycerin	Nitroglycerin	15	13
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Diazepam	Diazepam	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Invokana	Canagliflozin	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Finasteride	Finasteride	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nyamyc	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error